Alpha-Conotoxin MII: A Selective Nicotinic Receptor Probe
Alpha-Conotoxin MII: A Selective Nicotinic Receptor Probe
批准号:
7891168
负责人:
PAUL WHITEAKER
金额:
$35.66万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-02-01 至 2012-08-31
关键词:
AddressAdoptedAffectAminobutyric AcidsAnimalsBehavioralBindingBiological AssayBiotinChronicComplex MixturesConotoxinConus genusCorpus striatum structureDevelopmentDopamineDrosophila acetylcholine receptor alpha-subunitEngineeringEquilibriumExhibitsFamilyFundingGoalsGrantHealthHumanHybridsIndividualKnowledgeLabelLesionLigand BindingLigandsLocationMaintenanceMeasuresMediatingModelingMolecularMusMutationNeurotransmittersNicotineNicotine DependenceNicotinic ReceptorsParkinson DiseasePeptidesPerformancePlayPopulationProgress ReportsPropertyRadiolabeledResearch PersonnelRetinal ConeRoleSeriesSnailsSpecificitySystemToxinVariantalpha-Conotoxinalpha-conotoxin MIIanalogbasedesignexperiencegain of functiongamma-Aminobutyric Acidimprovedinsightmemberneurotransmissionnovelprogramsradiotracerreceptorresearch studyresponsesmoking cessationsuccesstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Nicotine produces behavioral effects through a diverse family of nicotinic acetylcholine receptors (nAChRs). Nicotine-evoked dopamine release is thought to play an important role in the establishment and maintenance of nicotine dependence, which undelies peoples' continued use of tobacoo products, despite their well-known dangers to health. alpha-conotoxin MII is a toxin isolated from the predatory cone-snail Conus magus, which distinguishes between subsets of nicotinic receptors. In the first funding periods of this grant, we used alpha-CtxMII to identify and analyse the nAChR populations that modulate nicotine-evoke dopamine release. We also began to study the effects of chronic nicotine exposure on these receptors, and how they are affected in models of Parkinson's Disease. In order to enhance the usefulness of alpha-CtxMII, we have also engineered variants which have incorporate new properties or increased its selectivity for particular nAChR populations. Experiments outlined in the current proposal will extend these studies further. 1) Chronic treatment and nicotinic subunit mutation will be used (alone, and in combination) to investigate how the nAChR populations characterized in the previous funding period interact with each other, and with the neurotransmitter systems that they modulate. 2) New alpha-CtxMII derivatives will be developed with two aims. First, to make alpha3beta2-nAChR subtype selective derivatives (we do not have such a compound at present, but this is a natually-expressed nAChR subtype that requires further study). Second, to produce alpha-CtxMII-based radiolabels that retain the original selectivity of [125l]alpha-CtxMII (which was developed in the previous funding periods), but with improved assay performance. This will improve out ability to measure and study these important nAChRs. 3) Synthesize and characterize derivatives of alpha-conotoxin ArIB, which has selectivity for alpha7-subtype nAChRs. We intend to develop a series of useful, highly-selective tools for the study of this naturally-occurring nAChR subtype. The proposed studies will provide further insights into the locations, numbers and functional roles of naturally-occurring nAChRs, and the interactions between them. It is likely that this increased understanding will, in turn, illuminate which nAChR subtypes are implicated in nicotine dependence, and thus assist in attempts to develop more-effective smoking cessation aids. These insights may also guide the design of nicotinic therapies for other conditions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Relevance of α-Conotoxin MII Sensitive Nicotinic Receptor Subtypes to Nicotine Addiction
-
批准号:10600540
-
项目类别:
-
资助金额:$55.0万
-
财政年份:2022
-
负责人:PAUL WHITEAKER
-
依托单位:
Relevance of α-Conotoxin MII Sensitive Nicotinic Receptor Subtypes to Nicotine Addiction
-
批准号:9212601
-
项目类别:
-
资助金额:$56.72万
-
财政年份:2017
-
负责人:PAUL WHITEAKER
-
依托单位:
High-Throughput Assay Development for Non-Nicotine Tobacco Components
-
批准号:8576344
-
项目类别:
-
资助金额:$23.01万
-
财政年份:2013
-
负责人:PAUL WHITEAKER
-
依托单位:
High-Throughput Assay Development for Non-Nicotine Tobacco Components
-
批准号:8660057
-
项目类别:
-
资助金额:$23.25万
-
财政年份:2013
-
负责人:PAUL WHITEAKER
-
依托单位:
HTS Assay Development for alpha6/3beta2beta3 Subtype Nicotinic Receptors
-
批准号:8212661
-
项目类别:
-
资助金额:$25.4万
-
财政年份:2011
-
负责人:PAUL WHITEAKER
-
依托单位:
Construction and Expression of Concatemeric alpha6beta2* Nicotinic Acetycholine R
-
批准号:7641663
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2009
-
负责人:PAUL WHITEAKER
-
依托单位:
Immunochemical Protocols for Nicotinic Receptors
-
批准号:6902770
-
项目类别:
-
资助金额:$18.61万
-
财政年份:2005
-
负责人:PAUL WHITEAKER
-
依托单位:
Immunochemical Protocols for Nicotinic Receptors
-
批准号:7031028
-
项目类别:
-
资助金额:$21.82万
-
财政年份:2005
-
负责人:PAUL WHITEAKER
-
依托单位:
Alpha-Conotoxin MII: A Selective Nicotinic Receptor Probe
-
批准号:8116617
-
项目类别:
-
资助金额:$35.53万
-
财政年份:1999
-
负责人:PAUL WHITEAKER
-
依托单位:
Alpha-Conotoxin MII: A Selective Nicotinic Receptor Probe
-
批准号:7317703
-
项目类别:
-
资助金额:$35.18万
-
财政年份:1999
-
负责人:PAUL WHITEAKER
-
依托单位:
Alpha-Conotoxin MII: A Selective Nicotinic Receptor Probe
-
批准号:7681686
-
项目类别:
-
资助金额:$35.06万
-
财政年份:1999
-
负责人:PAUL WHITEAKER
-
依托单位:
海外基金